Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 39, 2008, Pages 14993-14998

  Lam, Queenie Lai Kwan ^a   Ko, Otis King Hung ^a   Zheng, Bo Jian ^a   Lu, Liwei ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; INTERLEUKIN 17; LENTIVIRUS VECTOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TNFSF13B PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BAFF GENE; CELL DIFFERENTIATION; CELL LINE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; GENE; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PATHOGENESIS; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRAL GENE DELIVERY SYSTEM; ANIMAL; AUTOIMMUNE DISEASE; C57BL MOUSE; GENE THERAPY; GENETICS; HELPER CELL; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LENTIVIRINAE; RHEUMATOID ARTHRITIS;

LENTIVIRUS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; B-CELL ACTIVATING FACTOR; CELL LINE; GENE SILENCING; GENE THERAPY; HUMANS; IMMUNOSUPPRESSION; INTERLEUKIN-17; LENTIVIRUS; MICE; MICE, INBRED C57BL; RNA, SMALL INTERFERING; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 54449087291     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0806044105     Document Type: Article

References (38)

1. Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423:356-361.
2. Batten M, et al. (2000) BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 192:1453-1466.
3. Zhang M, et al. (2005) Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis. Int Immunol 17:1081-1092.
4. Ng LG, et al. (2004) B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol 173:807-817.
5. Stockinger B, Veldhoen M (2007) Differentiation and function of Th17 T cells. Curr Opin Immunol 19:281-286.
6. Nakae S, Nambu A, Sudo K, Iwakura Y (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171:6173-6177.
7. Lubberts E, Koenders MI, van den Berg WB (2005) The role of T-cell interleukin-17 in conducting destructive arthritis: Lessons from animal models. Arthritis Res Ther 7:29-37.
8. McInnes IB, Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7:429-442.
9. Smolen JS, Steiner G (2003) Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov 2:473-488.
10. Pelletier M, et al. (2003) Comparison of soluble decoy IgG fusion proteins of BAFF-R and BCMA as antagonists for BAFF. J Biol Chem 278:33127-33133.
11. Wang H, et al. (2001) TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Nat Immunol 2:632-637.
12. Gilbert JA, et al. (2006) Treatment of autoimmune hyperthyroidism in amurine model of Graves' disease with tumor necrosis factor-family ligand inhibitors suggests a key role for B cell activating factor in disease pathology. Endocrinology 147:4561-4568.
13. Huntington ND, et al. (2006) A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses. Int Immunol 18:1473-1485.
14. Bongartz T, et al. (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials. J Am Med Assoc 295:2275-2285.
15. Bettelli E, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-238.
16. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179-189.
17. Sutherland AP, et al. (2005) BAFF augments certain Th1-associated inflammatory responses. J Immunol 174:5537-5544.
18. Mackay F, Browning JL (2002) BAFF: A fundamental survival factor for B cells. Nat Rev Immunol 2:465-475.
19. Zhang M, et al. (2004) Novel function of TNF cytokines in regulating bone marrow B cell survival. Cell Mol Immunol 1:447-453.
20. Avery DT, et al. (2003) BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J Clin Invest 112:286-297.
21. MacLennan I, Vinuesa C (2002) Dendritic cells, BAFF, and APRIL: Innate players in adaptive antibody responses. Immunity 17:235-238.
22. Abdellatif AA, et al. (2006) Gene delivery to the spinal cord: Comparison between lentiviral, adenoviral, and retroviral vector delivery systems. J Neurosci Res 84:553-567.
23. Frimpong K, Spector SA (2000) Cotransduction of nondividing cells using lentiviral vectors. Gene Ther 7:1562-1569.
24. Schroder AE, Greiner A, Seyfert C, Berek C (1996) Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci USA 93:221-225.
25. Weyand CM, Goronzy JJ (2003) Ectopic germinal center formation in rheumatoid synovitis. Ann NY Acad Sci 987:140-149.
26. Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM (2001) T cell activation in rheumatoid synovium is B cell dependent. J Immunol 167:4710-4718.
27. Martin F, Chan AC (2004) Pathogenic roles of B cells in human autoimmunity; Insights from the clinic. Immunity 20:517-527.
28. Eisenberg R, Albert D (2006) B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus. Nat Clin Pract Rheumatol 2:20-27.
29. Badr G, et al. (2008) BAFF enhances chemotaxis of primary human B cells: A particular synergy between BAFF and CXCL13 on memory B cells. Blood 111:2744-2754.
30. Hirota K, et al. (2007) T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 204:41-47.
31. Alonzi T, et al. (1998) Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med 187:461-468.
32. Korn T, et al. (2007) IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448:484-487.
33. Harrington LE, et al. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123-1132.
34. Park H, et al. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6:1133-1141.
35. Camps M, et al. (2005) Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 11:936-943.
36. Lam QL, Zheng BJ, Jin DY, Cao X, Lu L (2007) Leptin induces CD40 expression through the activation of Akt in murine dendritic cells. J Biol Chem 282:27587-27597.
37. Lam QL, Liu S, Cao X, Lu L (2006) Involvement of leptin signaling in the survival and maturation of bone marrow-derived dendritic cells. Eur J Immunol 36:3118-3130.
38. Kimura A, Naka T, Kishimoto T (2007) IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc Natl Acad Sci USA 104:12099-12104.